About

Publications While At HealthPartners

selected publications

Journal Article

A randomized, phase III trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45). 

Journal of Clinical Oncology. 2022

Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer. 

European Journal of Cancer. 2021

Contact

full name

K. Moore

Quick Info

 

Collaboration

Co-author network

Map of science